This Personalized Protocol for Crohn’s, Colitis, and IBD is a Game-Changer in Natural Medicine

The use of natural medicine to cure illnesses and promote health and well-being has come a long way. In many cases, natural remedies are believed to have fewer side effects and to be more holistic in their approach to healing, as they often focus on addressing the underlying causes of illness rather than just treating the symptoms. Today, natural medicine is increasingly being integrated with modern medicine, with many healthcare providers recognizing the value of incorporating natural remedies into treating common health conditions.

One of the most common illnesses is gastroenteritis, which affects millions of people globally each year. Despite the advancement of modern medicine, acute forms of GE have affected 179 people worldwide and have led to 1 million hospitalizations. Meanwhile, 10 million people globally are living with IBD, Crohn’s disease, or Colitis. This large number of sufferers is attributed to the global inaccessibility of treatment and remedies – from high medicinal costs to a lack of proper assessment. One startup is aiming to bridge this gap by providing affordable, natural yet scientifically-verified remedies and accurate medical assessments.

Evinature is an Israel-based company that is conducting pioneering research on integrative therapies for inflammatory bowel disease (IBD). They develop, source, and distribute nutraceuticals that have been clinically shown to be effective. Using their proprietary online platform, their team gives patients worldwide access to accurate diagnosis and treatment.

The Evinature Vision

Evinature was founded on the hybrid of two medical philosophies. By combining modern and traditional medicine, they are able to offer safe, natural remedies that are widely accepted by the medical community. Their goal is for the healthcare industry to prioritize providing accurate medical assessments and affordable treatments to all patients, regardless of location.

Co-Founded by Prof. Shomron Ben-Horin M.D., Nir Salomon, and Apan Amos Damri, their team is committed to developing, testing, and verifying their products and then sharing them with the community, without considering patents or following trends.

Tailored Strategies and Guided Care

Evinature is a platform that prioritizes the needs of patients. Their team of experts understands that no two bodies are the same, so they carefully evaluate each patient and customize treatment plans to meet the specific needs of each individual. They strive to provide the most appropriate strategy for each patient's unique condition. Their Regular Patient Reports enable them to make precise adjustments to treatment plans, ensuring their effectiveness over time and keeping patients informed of their progress. Moreover, this information is important for their ongoing research to help them improve the speed of recovery for more patients.

The CurQD® Protocol

CurQD® is a precise formulation of clinically-proven herbal extracts that offer fast, long-lasting relief. Their team tested their formula in gold-standard placebo-controlled trials to find the most effective ratio for each stage of the process. The CurQD® Protocol covers all bases, ensuring a fast, safe and effective solution for every individual.

After a patient’s assessment, their team will recommend one of five protocols. Each six-week protocol includes a set of three products that are most suitable for their current condition based on clinical trials. Before a patient finishes a protocol, the team at Evinature will check in with a free follow-up to determine the next course of action. Regular follow-ups are a vital part of the CurQD® Protocol, and their team is committed to ensuring that patients maximize their protocol and checking in regularly to make adjustments according to patient’s responses.

Evinature values evidence above trends. As healthcare professionals, they prioritize product quality and scientific integrity above everything else. They only distribute products and offer treatments that have undergone clinical trials, which are considered the highest standard.